-
Loading metrics
Open Access
Peer-reviewed
Research Article
ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer
-
Guadalupe Lorenzatti Hiles ,
Contributed equally to this work with: Guadalupe Lorenzatti Hiles, Amanda Bucheit
Affiliations Division of Urologic Oncology, Department of Urology, University of Michigan, Ann Arbor, Michigan, United States of America, Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, United States of America, Translational Oncology Program, University of Michigan, Ann Arbor, Michigan, United States of America
⨯ -
Amanda Bucheit ,
Contributed equally to this work with: Guadalupe Lorenzatti Hiles, Amanda Bucheit
Affiliation Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America
⨯ -
John R. Rubin,
Affiliations Division of Urologic Oncology, Department of Urology, University of Michigan, Ann Arbor, Michigan, United States of America, Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, United States of America, Translational Oncology Program, University of Michigan, Ann Arbor, Michigan, United States of America
⨯ -
Alexandra Hayward,
Affiliations Division of Urologic Oncology, Department of Urology, University of Michigan, Ann Arbor, Michigan, United States of America, Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, United States of America, Translational Oncology Program, University of Michigan, Ann Arbor, Michigan, United States of America, School of Public Health, University of Michigan, Ann Arbor, Michigan, United States of America
⨯ -
Angelica L. Cates,
Affiliations Division of Urologic Oncology, Department of Urology, University of Michigan, Ann Arbor, Michigan, United States of America, Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, United States of America, Translational Oncology Program, University of Michigan, Ann Arbor, Michigan, United States of America
⨯ -
Kathleen C. Day,
Affiliations Division of Urologic Oncology, Department of Urology, University of Michigan, Ann Arbor, Michigan, United States of America, Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, United States of America, Translational Oncology Program, University of Michigan, Ann Arbor, Michigan, United States of America
⨯ -
Layla El-Sawy,
Affiliations Division of Urologic Oncology, Department of Urology, University of Michigan, Ann Arbor, Michigan, United States of America, Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, United States of America, Translational Oncology Program, University of Michigan, Ann Arbor, Michigan, United States of America, European Egyptian Pharmaceuticals, Alexandria, Egypt
⨯ -
L. Priya Kunju,
Affiliation Department of Pathology, University of Michigan, Ann Arbor, Michigan, United States of America
⨯ -
Stephanie Daignault,
Affiliation Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, United States of America
⨯ -
Cheryl T. Lee,
Affiliations Division of Urologic Oncology, Department of Urology, University of Michigan, Ann Arbor, Michigan, United States of America, Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, United States of America
⨯ -
Monica Liebert,
Affiliations Division of Urologic Oncology, Department of Urology, University of Michigan, Ann Arbor, Michigan, United States of America, Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, United States of America, Translational Oncology Program, University of Michigan, Ann Arbor, Michigan, United States of America
⨯ -
Maha Hussain,
Affiliations Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, United States of America, School of Public Health, University of Michigan, Ann Arbor, Michigan, United States of America
⨯ -
Mark L. Day
* E-mail: mday@umich.edu
Affiliations Division of Urologic Oncology, Department of Urology, University of Michigan, Ann Arbor, Michigan, United States of America, Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, United States of America, Translational Oncology Program, University of Michigan, Ann Arbor, Michigan, United States of America
⨯
ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer
- Guadalupe Lorenzatti Hiles,
- Amanda Bucheit,
- John R. Rubin,
- Alexandra Hayward,
- Angelica L. Cates,
- Kathleen C. Day,
- Layla El-Sawy,
- L. Priya Kunju,
- Stephanie Daignault,
- Cheryl T. Lee
- Published: March 1, 2016
- https://doi.org/10.1371/journal.pone.0150138